While research is still emerging and clinical guidelines arent yet standardized, its widespread benefits in tissue repair, immune regulation, and inflammation control make it a promising candidate for integrative treatment plans aimed at BPC-157 healing chronic Lyme
Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides
According to available research, glutathione injections are generally well-tolerated when administered by a qualified medical professional1
Similarly, investigations in models of gastric ulceration and inflammatory bowel disease have demonstrated meaningful mucosal protective and healing effects
While small air bubbles in subcutaneous injections aren't dangerous, they displace product and slightly reduce actual dose delivered